Osteoporosis Clinical Trial
— BOESTOfficial title:
Treatment of Osteoporosis With Unfocused Extracorporeal Shock Wave Therapy: Pilot Study
Verified date | October 2017 |
Source | UMC Utrecht |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Rationale: Osteoporotic fractures are associated with high morbidity and mortality. This is
why prevention of these fractures is important. The investigators have shown in animal
studies that a single treatment with unfocused extracorporeal shock wave therapy leads to
highly increased bone mass and improved biomechanical properties. Unfocused extracorporeal
shock wave therapy could have important implications for the prevention of osteoporotic
fractures.
Objective: To assess the effect of unfocused extracorporeal shock wave therapy on bone mass.
Study design: A clinical pilot study. Study population: Twelve female patients are eligible
if they are undergoing elective surgery of the lower extremity or elective spinal surgery
under general anesthesia in the investigators hospital.
Intervention: When the patient is under general anaesthesia he/she will receive 3000
unfocused extracorporeal shock waves (energy flux density 0.3mJ/mm2) to one distal forearm.
The contra lateral forearm will not be treated and serves as a control.
Main study parameters/endpoints:
The investigators will examine the effect on bone mass with the use of repeated dual energy
X-ray absorptiometry measurements. These results are necessary to calculate the number of
patients that are needed for larger studies. Furthermore, the investigators will assess
patient's discomfort.
Nature and extent of the burden and risks associated with participation, benefit and group
relatedness: General anaesthesia is performed during treatment and pain after the procedure
will be evaluated using pain scales and, if necessary pain medication will be prescribed by
the orthopaedic surgeon. The dual energy X-ray absorptiometry-scans and X-rays will cause
very low radiation exposure to the patient.
Status | Completed |
Enrollment | 12 |
Est. completion date | September 19, 2016 |
Est. primary completion date | September 19, 2016 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 50 Years to 80 Years |
Eligibility |
Inclusion Criteria: - female sex, age 50-80 years, normal dietary intake inclusive calcium and/or milk products and willing to participate Exclusion Criteria: - skin disease, systemic corticosteroid use, known systemic disease that interacts with bone (eg. rheumatoid arthritis, multiple myeloma, hyper(para)thyroidism, Paget's disease or Cushing's disease) or a previous wrist fracture |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
UMC Utrecht |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Bone mineral density will be assessed with the use of repeated dual energy X-ray absorptiometry measurements | 12 weeks | ||
Primary | Bone mineral density will be assessed with the use of repeated dual energy X-ray | 6 weeks | ||
Secondary | Pain on the VAS scale | day before and first week after treatment | ||
Secondary | Patient's side effects and complications on a questionnaire | 12 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT06287502 -
Efficacy of Structured Exercise-Nutritional Intervention on Sarcopenia in Patients With Osteoporosis
|
N/A | |
Completed |
NCT03822078 -
Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Denosumab (AMG 162) in Japanese Postmenopausal Women
|
Phase 1 | |
Recruiting |
NCT05845021 -
Surgeon-Initiated Bone Health Referral Pathway in Patients Undergoing Lower Extremity Arthroplasty
|
N/A | |
Completed |
NCT00092066 -
A Study to Evaluate the Safety, Tolerability, and Efficacy of an Investigational Drug and Dietary Supplement in Men and Postmenopausal Women With Osteoporosis (0217A-227)
|
Phase 3 | |
Recruiting |
NCT04754711 -
Interest of Nutritional Care of Children With Sickle Cell Disease on Bone Mineral Density and Body Composition
|
N/A | |
Completed |
NCT04736693 -
Replication of the HORIZON Pivotal Fracture Trial in Healthcare Claims Data
|
||
Not yet recruiting |
NCT06431867 -
Primary Care Management of Osteoporosis in Older Women
|
||
Completed |
NCT02922478 -
Role of Comorbidities in Chronic Heart Failure Study
|
||
Recruiting |
NCT02635022 -
Fragility Fracture Liaison Service and Anti-osteoporosis Medication Monitoring Service Study
|
||
Recruiting |
NCT02616627 -
Association Between DXA Results and the Complications, Clinical Courses and Outcomes in Chronic Dialysis Patients
|
||
Active, not recruiting |
NCT02617303 -
Prevention of Falls and Its Consequences in Elderly People
|
N/A | |
Completed |
NCT02566655 -
Clinical Trial of Intravenous Infusion of Fucosylated Bone Marrow Mesenchyme Cells in Patients With Osteoporosis
|
Phase 1 | |
Not yet recruiting |
NCT02223572 -
Secondary Fracture Prevention in Patients Who Suffered From Osteoporotic Fracture
|
N/A | |
Completed |
NCT02559648 -
Denosumab vs Placebo in Patients With Thalassemia Major and Osteoporosis
|
Phase 2 | |
Completed |
NCT03420716 -
Symbiotic Yogurt, Calcium Absorption and Bone Health in Young Adult Women
|
N/A | |
Unknown status |
NCT01913834 -
Nasally and sc Administered Teriparatide in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT02003716 -
DeFRA Questionnaire as an Anamnestic Form
|
N/A | |
Not yet recruiting |
NCT01854086 -
Compliance and Persistence With Osteoporosis Treatment and Attitude Towards Future Therapy Among Post-menopausal Israeli Women During Drug Treatment or Drug Holiday
|
N/A | |
Completed |
NCT01694784 -
Understanding and Discouraging Overuse of Potentially Harmful Screening Tests
|
N/A | |
Completed |
NCT01401556 -
C-STOP Fracture Trial
|
N/A |